1
Clinical Trials associated with LEISH-F3 adjuvanted with SLA-SE(IDRI)A Phase 1, Open-Label Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of the LEISH-F3 + SLA-SE Vaccine Compared to LEISH-F3 + GLA-SE Vaccine in Healthy Adult Subjects
The purpose of this study is to compare the safety, tolerability, and immunogenicity in healthy adult subjects of an investigational vaccine being developed for the prevention of visceral leishmaniasis.
100 Clinical Results associated with LEISH-F3 adjuvanted with SLA-SE(IDRI)
100 Translational Medicine associated with LEISH-F3 adjuvanted with SLA-SE(IDRI)
100 Patents (Medical) associated with LEISH-F3 adjuvanted with SLA-SE(IDRI)
100 Deals associated with LEISH-F3 adjuvanted with SLA-SE(IDRI)